On May 31, 2023 Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, reported that Dr. James Breitmeyer, Oncternal’s President and Chief Executive Officer will present at the 2023 Jefferies Healthcare Conference (Press release, Oncternal Therapeutics, MAY 31, 2023, View Source [SID1234632280]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Jefferies Healthcare Conference
Date: Wednesday, June 7, 2023 at 4:30pm (ET) in Track 7

During the conference, Dr. Breitmeyer and members of Oncternal’s management team will conduct one-on-one meetings with registered investors.

The webcast will be available online at investor.oncternal.com, for at least 30 days after the event.